Back to RecallTracker
Health Canada Health products

Important Safety Information on ACTEMRA® (tocilizumab) - Risk of Hepatotoxicity

Issued May 21, 2019
Issue
Serious cases of drug-induced liver injuries (DILI) have been reported in patients treated with ACTEMRA, including cases of acute liver failure requiring a transplant. There have been cases of serious liver injury reported from Canada.